Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

被引:5
|
作者
Papadopoulos, Efthymios [1 ,2 ]
Alibhai, Shabbir M. H. [2 ,3 ,4 ]
Tomlinson, George A. [3 ,4 ,6 ]
Matthew, Andrew G. [3 ,4 ]
Nesbitt, Michael [5 ]
Finelli, Antonio [3 ,5 ]
Trachtenberg, John [3 ,5 ]
Santa Mina, Daniel [1 ,2 ,3 ]
机构
[1] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
Prostate cancer; Low-risk disease; Active surveillance; Physical activity; Treatment; EXERCISE; LIFE;
D O I
10.1007/s10552-019-01211-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Epidemiologic data suggest that high levels of physical activity (PA) may reduce the risk of disease progression in men with prostate cancer (PCa), but it is unknown whether PA can delay the requirement for definitive treatment for those on active surveillance (AS). We investigated the influence of PA post-diagnosis on AS discontinuation in men with low-risk disease. Methods The effect of PA on the time to AS discontinuation was assessed in 421 patients, of whom 107 underwent additional PCa treatment over a median of 2.5 years. Results Using Cox regression models, we found that PA was not significantly associated with time to curative treatment initiation. Prostate-specific antigen (PSA) most proximal to AS initiation (HR, 1.11; 95% CI 1.03 to 1.21) and the number of positive cores (HR, 1.34; 95% CI 1.12 to 1.61) at diagnosis were associated with a significantly increased risk of discontinuing AS. Conclusion Our findings suggest that PA during AS for PCa does not significantly influence time to curative treatment.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 50 条
  • [31] Physical activity and prostate gene expression in men with low-risk prostate cancer.
    Magbanua, Mark Jesus Mendoza
    Richman, Erin L.
    Sosa, Eduardo V.
    Jones, Lee
    Simko, Jeffrey
    Shinohara, Katsuto
    Haqq, Christopher M.
    Carroll, Peter
    Chan, June M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [32] Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center
    M R Abern
    M R Bassett
    M Tsivian
    L L Bañez
    T J Polascik
    M N Ferrandino
    C N Robertson
    S J Freedland
    J W Moul
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 85 - 90
  • [33] Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center
    Abern, M. R.
    Bassett, M. R.
    Tsivian, M.
    Banez, L. L.
    Polascik, T. J.
    Ferrandino, M. N.
    Robertson, C. N.
    Freedland, S. J.
    Moul, J. W.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (01) : 84 - 89
  • [34] Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer?
    Xu, Ming
    Zhang, Li
    Liang, Chaozhao
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (08) : 1287 - 1289
  • [35] Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer
    Davison, B. Joyce
    Oliffe, John L.
    Pickles, Tom
    Mroz, Lawrence
    ONCOLOGY NURSING FORUM, 2009, 36 (01) : 89 - 96
  • [36] ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IN MEN UNDER 60 YEARS OF AGE
    Salari, Keyan
    Kuppermann, David
    Preston, Mark
    Dahl, Douglas
    Efstathiou, Jason
    Blute, Michael
    Vesprini, Danny
    Loblaw, Andrew
    Zietman, Anthony
    Klotz, Laurence
    Feldman, Adam
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1051 - E1052
  • [37] Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer?
    Ming Xu
    Li Zhang
    Chaozhao Liang
    International Urology and Nephrology, 2016, 48 : 1287 - 1289
  • [38] Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer
    Taylor, Kathryn L.
    Hoffman, Richard M.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst
    Lobo, Tania
    Kelly, Scott P.
    Shan, Jun
    Aaronson, David
    Tomko, Catherine A.
    Starosta, Amy J.
    Hagerman, Charlotte J.
    Van Den Eeden, Stephen K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (08) : 1240 - 1250
  • [39] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [40] Active Surveillance for Low-Risk Prostate Cancer in Black Patients
    Butler, Santino
    Muralidhar, Vinayak
    Chavez, Janice
    Fullerton, Zoe
    Mahal, Aman
    Nezolosky, Michelle
    Vastola, Marie
    Zhao, Shuang G.
    D'Amico, Anthony V.
    Dess, Robert T.
    Feng, Felix Y.
    King, Martin T.
    Mouw, Kent W.
    Spratt, Daniel E.
    Quoc-Dien Trinh
    Nguyen, Paul L.
    Rebbeck, Timothy R.
    Mahal, Brandon A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21): : 2070 - 2072